Literature DB >> 9726246

Uncoupling protein 3 is reduced in skeletal muscle of NIDDM patients.

A Krook1, J Digby, S O'Rahilly, J R Zierath, H Wallberg-Henriksson.   

Abstract

Two recently described proteins in the mitochondrial uncoupling protein (UCP) family, UCP-2 and UCP-3, have been linked to phenotypes of obesity and NIDDM. We determined the mRNA levels of UCP-2 and UCP-3 in skeletal muscle of NIDDM patients and of healthy control subjects. No difference in the mRNA levels or in the protein expression of UCP-2 was observed between the two groups. In contrast, mRNA levels of UCP-3 were significantly reduced in skeletal muscle of NIDDM patients compared with control subjects. In the NIDDM patients, a positive correlation between UCP-3 expression and whole-body insulin-mediated glucose utilization rate was also noted. These results suggest that UCP-3 regulation may be altered in states of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726246     DOI: 10.2337/diabetes.47.9.1528

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

Review 1.  Uncoupling proteins: role in insulin resistance and insulin insufficiency.

Authors:  Catherine B Chan; Mary-Ellen Harper
Journal:  Curr Diabetes Rev       Date:  2006-08

2.  UCP2 -866G/A and Ala55Val, and UCP3 -55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study.

Authors:  K Xu; M Zhang; D Cui; Y Fu; L Qian; R Gu; M Wang; C Shen; R Yu; T Yang
Journal:  Diabetologia       Date:  2011-07-13       Impact factor: 10.122

Review 3.  The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP.

Authors:  D Ricquier; F Bouillaud
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

4.  Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes.

Authors:  Anita Ost; Kristoffer Svensson; Iida Ruishalme; Cecilia Brännmark; Niclas Franck; Hans Krook; Per Sandström; Preben Kjolhede; Peter Strålfors
Journal:  Mol Med       Date:  2010-03-26       Impact factor: 6.354

5.  Lack of UCP3 does not affect skeletal muscle mitochondrial function under lipid-challenged conditions, but leads to sudden cardiac death.

Authors:  Miranda Nabben; Bianca W J van Bree; Ellen Lenaers; Joris Hoeks; Matthijs K C Hesselink; Gert Schaart; Marion J J Gijbels; Jan F C Glatz; Gustavo J J da Silva; Leon J de Windt; Rong Tian; Elise Mike; Darlene G Skapura; Xander H T Wehrens; Patrick Schrauwen
Journal:  Basic Res Cardiol       Date:  2014-10-25       Impact factor: 17.165

6.  Serine/threonine protein kinase 25 (STK25): a novel negative regulator of lipid and glucose metabolism in rodent and human skeletal muscle.

Authors:  A Nerstedt; E Cansby; C X Andersson; M Laakso; A Stančáková; M Blüher; U Smith; M Mahlapuu
Journal:  Diabetologia       Date:  2012-03-04       Impact factor: 10.122

7.  Endurance training increases stimulation of uncoupling of skeletal muscle mitochondria in humans by non-esterified fatty acids: an uncoupling-protein-mediated effect?

Authors:  M Tonkonogi; A Krook; B Walsh; K Sahlin
Journal:  Biochem J       Date:  2000-11-01       Impact factor: 3.857

Review 8.  Skeletal muscle insulin resistance: the interplay of local lipid excess and mitochondrial dysfunction.

Authors:  Lisa Chow; Arthur From; Elizabeth Seaquist
Journal:  Metabolism       Date:  2009-09-18       Impact factor: 8.694

9.  Transcription of the human uncoupling protein 3 gene is governed by a complex interplay between the promoter and intronic sequences.

Authors:  A Girousse; G Tavernier; C Tiraby; L Lichtenstein; J S Iacovoni; A Mairal; F Villarroya; D Langin
Journal:  Diabetologia       Date:  2009-05-26       Impact factor: 10.122

10.  RNA sequencing reveals potential interacting networks between the altered transcriptome and ncRNome in the skeletal muscle of diabetic mice.

Authors:  Devesh Kesharwani; Amit Kumar; Mukta Poojary; Vinod Scaria; Malabika Datta
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.